Role of inflammation in the progression of heart failure - PubMed (original) (raw)

Review

Role of inflammation in the progression of heart failure

Arne Yndestad et al. Curr Cardiol Rep. 2007 May.

Abstract

Chronic heart failure (HF) is a disorder characterized in part by immune activation and inflammation. Thus, patients with HF have elevated levels of a number of inflammatory cytokines, both in the circulation and in the failing heart itself. Several mechanisms for this immune activation, which are not mutually exclusive, have been suggested, including neurohormonal activation, hemodynamic overload, and activation of the innate immune system secondary to cardiac stress. Importantly, experimental studies have shown that inflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1b, and monocyte chemoattractant peptide-1 may contribute to the development and progression of HF by promoting myocardial hypertrophy, activating matrix metalloproteinases, provoking contractile dysfunction, and inducing apoptosis. However, inflammatory cytokines may also have adaptive and cardioprotective effects. This important aspect of cytokine biology must be kept in mind when designing new immunomodulatory treatment modalities in HF.

PubMed Disclaimer

Similar articles

• The contributions of dipeptidyl peptidase IV to inflammation in heart failure.
  de Almeida Salles T, Zogbi C, de Lima TM, de Godoi Carneiro C, Garcez AT, Barbeiro HV, Antonio EL, Dos Santos L, da Costa Pereira A, Tucci PJ, de Paula Faria D, Soriano FG, Girardi AC. de Almeida Salles T, et al. Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1760-72. doi: 10.1152/ajpheart.00735.2015. Epub 2016 May 3. Am J Physiol Heart Circ Physiol. 2016. PMID: 27199127
• Inflammatory cytokines in heart failure: mediators and markers.
  Gullestad L, Ueland T, Vinge LE, Finsen A, Yndestad A, Aukrust P. Gullestad L, et al. Cardiology. 2012;122(1):23-35. doi: 10.1159/000338166. Epub 2012 Jun 12. Cardiology. 2012. PMID: 22699305 Review.
• The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure.
  Briasoulis A, Androulakis E, Christophides T, Tousoulis D. Briasoulis A, et al. Heart Fail Rev. 2016 Mar;21(2):169-76. doi: 10.1007/s10741-016-9533-z. Heart Fail Rev. 2016. PMID: 26872673 Review.
• Systemic inflammation in heart failure--the whys and wherefores.
  Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P. Yndestad A, et al. Heart Fail Rev. 2006 Mar;11(1):83-92. doi: 10.1007/s10741-006-9196-2. Heart Fail Rev. 2006. PMID: 16819581 Review.
• Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure.
  Hanna A, Frangogiannis NG. Hanna A, et al. Cardiovasc Drugs Ther. 2020 Dec;34(6):849-863. doi: 10.1007/s10557-020-07071-0. Epub 2020 Sep 9. Cardiovasc Drugs Ther. 2020. PMID: 32902739 Free PMC article. Review.

Cited by

• Effects of interleukin-33 on cardiac fibroblast gene expression and activity.
  Zhu J, Carver W. Zhu J, et al. Cytokine. 2012 Jun;58(3):368-79. doi: 10.1016/j.cyto.2012.02.008. Epub 2012 Mar 23. Cytokine. 2012. PMID: 22445500 Free PMC article.
• Identification of stable reference genes for lipopolysaccharide-stimulated macrophage gene expression studies.
  Kalagara R, Gao W, Glenn HL, Ziegler C, Belmont L, Meldrum DR. Kalagara R, et al. Biol Methods Protoc. 2016 Dec 27;1(1):bpw005. doi: 10.1093/biomethods/bpw005. eCollection 2016 Mar. Biol Methods Protoc. 2016. PMID: 32161782 Free PMC article.
• The Effect of Wenxin Keli on the mRNA Expression Profile of Rabbits with Myocardial Infarction.
  Zheng M, Liu Z, Liu N, Hou C, Pu J, Zhang S. Zheng M, et al. Evid Based Complement Alternat Med. 2016;2016:2352614. doi: 10.1155/2016/2352614. Epub 2016 Oct 24. Evid Based Complement Alternat Med. 2016. PMID: 27843475 Free PMC article.
• Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis.
  Virzì GM, Torregrossa R, Cruz DN, Chionh CY, de Cal M, Soni SS, Dominici M, Vescovo G, Rosner MH, Ronco C. Virzì GM, et al. Cardiorenal Med. 2012 Feb;2(1):33-42. doi: 10.1159/000335499. Epub 2012 Jan 20. Cardiorenal Med. 2012. PMID: 22493601 Free PMC article.
• Immune-inflammatory concept of the pathogenesis of chronic heart failure in dogs with dilated cardiomyopathy.
  Vatnikov Y, Rudenko A, Rudenko P, Kulikov E, Karamyan A, Lutsay V, Medvedev I, Byakhova V, Krotova E, Molvhanova M. Vatnikov Y, et al. Vet World. 2019 Sep;12(9):1491-1498. doi: 10.14202/vetworld.2019.1491-1498. Vet World. 2019. PMID: 31749587 Free PMC article.

References

1. 1. Cardiovasc Res. 1998 Dec;40(3):426-32 - PubMed
2. 1. J Mol Cell Cardiol. 2002 Oct;34(10):1309-16 - PubMed
3. 1. Circulation. 2005 May 17;111(19):2461-8 - PubMed
4. 1. Lancet. 1999 May 29;353(9167):1838-42 - PubMed
5. 1. J Am Coll Cardiol. 1996 Apr;27(5):1201-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal